Search - tctmd.com

Displaying 321 - 340 of 1391

Sort: Relevancy | Date

Presentation

10-Year Clinical Outcome After Randomization to Sirolimus- or Paclitaxel-Eluting Coronary stents

February 13, 2017

$The Coronary Sinus Reducer: A Device Based Therapy for Refractory Angina$

Presentation JIM 2017

The Coronary Sinus Reducer: A Device Based Therapy for Refractory Angina

Presenter: Francesco Giannini

February 10, 2017

Presentation JIM 2017

PiCSO to Reduce Infarct Size and Improve Functional recovery after STEMI

Presenter: Mohaned Egred

February 10, 2017

Presentation JIM 2017

Clinical Case: PCI in AF Patient

Presenter: Ferdinando Varbella

February 10, 2017

Presentation JIM 2017

Clinical Case: High-Risk ACS

Presenter: Alberto Menozzi

February 10, 2017

Presentation JIM 2017

The Future of Long Term Antiplatelet therapy: Is life Long Aspirin Still Necessary?

Presenter: Roxana Mehran

February 10, 2017

Presentation JIM 2017

The FASTER the GPI infusion…the better the reperfusion

Presenter: Marco Valgimigli

February 10, 2017

Presentation JIM 2017

The COMBO Plus Dual Therapy Stent: Clinical Update and Experience

Presenter: Gennaro Sardella

February 09, 2017

Presentation CHIP Florida 2017

Mitigating Operator Risk in Higher-Risk Coronary Procedures

Presenter: Tanveer Rab

January 21, 2017

Presentation CHIP Florida 2017

Case: 79 year old male- HTN, HLD, IDDM, CKD, h/o CVA w/o major deficits

Presenter: Jonathan Scharfstein

January 20, 2017

Presentation CHIP Florida 2017

Evolution of Left Main Percutaneous Revascularization Advancement to a Standard of Care

Presenter: David E. Kandzari

January 20, 2017

Presentation

Association of Rapid Care Process Implementation With Reperfusion Times Across STEMI Networks

Presenter: Christopher Fordyce

January 18, 2017

Presentation

Culprit Vessel vs Multivessel vs In-Hospital Staged PCI for STEMI and Multivessel Disease

Presenter: M.B. Iqbal

January 09, 2017

Presentation AHA 2016

Arterial Revascularization Trial (ART)

Presenter: David P. Taggart

November 15, 2016

AEGIS-I Trial: The Safety and Tolerability of CSL112

Presentation AHA 2016

The Safety and Tolerability of CSL112, a Reconstituted, Infusible, Plasma-Derived Human ApoA-I, After Acute Myocardial Infarction: The ApoA-I Event reducingG in Ischemic Syndromes I Trial (AEGIS-I)

Presenter: Michael Gibson

November 15, 2016

Presentation AHA 2016

FUnctional Testing Underlying REvascularization: The FUTURE trial

Presenter: Gilles Rioufol

November 15, 2016

Presentation Cardiovascular Interventions 2016

It's Not All About the Epicardial Vessel... Pay Attention to the Microvasculature!

Presenter: Bruce Samuels

November 11, 2016

Presentation Cardiovascular Interventions 2016

Unprotected Left Main Stenting

Presenter: Paul S. Teirstein

November 10, 2016

Presentation Cardiovascular Interventions 2016

Physiology As Essential Skill - How to be an expert: Caveats, Shortcuts

Presenter: Nils P. Johnson

November 09, 2016

Presentation Cardiovascular Interventions 2016

PCI for STEMI: Fix the Culprit Lesion, or Fix All of the Lesions

Presenter: James Hermiller

November 08, 2016

Advertisement

10-Year Clinical Outcome After Randomization to Sirolimus- or Paclitaxel-Eluting Coronary stents

The Coronary Sinus Reducer: A Device Based Therapy for Refractory Angina

PiCSO to Reduce Infarct Size and Improve Functional recovery after STEMI

Clinical Case: PCI in AF Patient

Clinical Case: High-Risk ACS

The Future of Long Term Antiplatelet therapy: Is life Long Aspirin Still Necessary?

The FASTER the GPI infusion…the better the reperfusion

The COMBO Plus Dual Therapy Stent: Clinical Update and Experience

Mitigating Operator Risk in Higher-Risk Coronary Procedures

Case: 79 year old male- HTN, HLD, IDDM, CKD, h/o CVA w/o major deficits

Evolution of Left Main Percutaneous Revascularization Advancement to a Standard of Care

Association of Rapid Care Process Implementation With Reperfusion Times Across STEMI Networks

Culprit Vessel vs Multivessel vs In-Hospital Staged PCI for STEMI and Multivessel Disease

Arterial Revascularization Trial (ART)

The Safety and Tolerability of CSL112, a Reconstituted, Infusible, Plasma-Derived Human ApoA-I, After Acute Myocardial Infarction: The ApoA-I Event reducingG in Ischemic Syndromes I Trial (AEGIS-I)

FUnctional Testing Underlying REvascularization: The FUTURE trial

It's Not All About the Epicardial Vessel... Pay Attention to the Microvasculature!

Unprotected Left Main Stenting

Physiology As Essential Skill - How to be an expert: Caveats, Shortcuts

PCI for STEMI: Fix the Culprit Lesion, or Fix All of the Lesions

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content